Company Filing History:
Years Active: 2012-2023
Title: Dejian Xie: Innovator in Pharmaceutical Chemistry
Introduction
Dejian Xie is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 5 patents, his work focuses on innovative solutions for treating various diseases.
Latest Patents
One of his latest patents is titled "Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof." This invention relates to novel 'reverse amide' compounds that include a zinc chelator group. These compounds are designed to inhibit HDAC6 and can be utilized in the treatment of diseases associated with this enzyme. Another significant patent is for "Substituted indolo 4,3 FG quinolines useful for treating migraine." This patent provides pharmaceutical compositions that are effective in treating, preventing, or ameliorating medical disorders such as migraines. The compounds disclosed also include methods for agonizing and antagonizing receptors, as well as regulating serotonin transport.
Career Highlights
Dejian Xie has worked with notable companies in the pharmaceutical industry, including Acetylon Pharmaceuticals, Inc. and Map Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Dejian has collaborated with esteemed colleagues such as John Henry Van Duzer and Ralph Mazitschek. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Dejian Xie's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.